CEOs at funded Biotechnology Research startups

Adamlead has 9 CEOs at Biotechnology Research startups with a known funding date. Companies with the most on file include Until, Generation Lab, NewLimit. Preview a sample below, or sign up to reveal contact details across the segment.

Top industries

Biotechnology Research · 9

Seniority

C-level · 9

Top locations

San Francisco, United States · 5Indianapolis, United States · 1Cambridge, United States · 1

Employer size

11-50 · 551-200 · 22-10 · 2

Showing 9 of 9 contactsSign up to see all contacts

Name	Title	Company	Email
Alina Rui Su	Founder & CEO	Generation Lab	a***@generationlab.comVerified
Blake Byers	Co-Founder	NewLimit	b***@newlimit.comVerified
Celine Halioua	Founder & CEO	Loyal	c***@loyal.comVerified
Diana Caldwell	Chief Executive Officer	Amplified Sciences	d***@amplifiedsci.comVerified
Hunter Davis	CSO, Co-founder	Until	h***@untillabs.comUnverified
Jacob Becraft	Co-Founder and CEO	Strand Therapeutics	j***@strandtx.comVerified
Laura Deming	CEO, Co-founder	Until	l***@untillabs.comUnverified
Ritish Patnaik	Founder	Curve Biosciences	r***@curvebio.comVerified
Tyler Rose	Founder, CEO	Bindwell	t***@bindwell.aiVerified

How to approach CEOs at a funded startup

What they own: At seed and Series A the CEO is usually still the final decision-maker on anything strategic: the first sales and marketing hires, agencies, and the core tools the team standardises on. Founders often hold the CEO title, which is why founder titles are included here.
What they evaluate after a round: Right after a round, the CEO is turning the pitch deck into a plan — hiring against it, picking vendors to hit the milestones the next round will be judged on, and cutting anything that doesn't move those numbers.
How to open the conversation: Reference the round and one concrete outcome you'd move before the next one. Keep it short: a founder's inbox gets heavier the week an announcement goes out, and a two-line note tied to their plan beats a long introduction.